ZY19489 is a novel anti-malarial compound active against all current clinical strains of P. falciparum and P. vivax, including drug resistant strains
It recommends using the vaccine to prevent the spread of the disease
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
Inclacumab was generally well tolerated in THRIVE-131
A new weapon in the global fight against malaria
Groundbreaking collaboration harnesses AI-driven insights and advanced manufacturing to create next-generation adjuvants for emerging biological threats
The grant is designated for the research and development of Pyronaridine
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Subscribe To Our Newsletter & Stay Updated
